Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Concise report

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

Authors

T I Temekonidis PubMed articles Google scholar articles
Y Alamanos PubMed articles Google scholar articles
S N Nikas PubMed articles Google scholar articles
D V Bougias PubMed articles Google scholar articles
A N Georgiadis PubMed articles Google scholar articles
P V Voulgari PubMed articles Google scholar articles
A A Drosos PubMed articles Google scholar articles

Correspondence to:
Professor A A Drosos
Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece; adrososcc.uoi.gr

Citation

Temekonidis TI, Alamanos Y, Nikas SN, et al

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

Annals of the Rheumatic Diseases 2003;62:1218-1220.

Publication history

Accepted July 29, 2003
First published November 21, 2003.

Online issue publication

April 20, 2023

Copyright information

Copyright 2003 by Annals of the Rheumatic Diseases